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Objective: To assess outcome of valve repair in patients with aortic valve regurgi-
tation with emphasis on incidence and risk of reoperation.
Methods: We retrospectively reviewed 160 consecutive patients (127 men) who
underwent aortic valve repair between 1986 and 2001. Ages ranged from 14 to 84
years (mean 55  17 years). Patients were categorized according to the main
etiology of valve disease; 63 patients (39%) had annular dilation leading to central
leakage, 54 (34%) had bicuspid valve, 34 (21%) with tricuspid valve had cusp
prolapse, and 9 (6%) had cusp perforation. Repair methods included commissural
plication (n  154, 96%), partial cusp resection with plication (n  47, 29%),
resuspension or cusp shortening (n  44, 28%), and closure of cusp perforation (n
 10, 6%).
Results: There was 1 early death (0.6%). Two patients required re-repair of the
aortic valve during initial hospitalization. During a mean follow-up of 4.2 years,
there were 16 late deaths. Overall, 16 of 159 hospital survivors had late reoperation
on the aortic valve (mean interval 2.8 years) without early mortality. Risks of
reoperation on the aortic valve were 9%, 11%, and 15% at 3, 5, and 7 years,
respectively.
Conclusions: Aortic valve repair can be performed with low risk and excellent
freedom from valve-related morbidity and mortality. Late recurrence of aortic valve
regurgitation led to reoperation in 8.8% of patients, but mortality associated with
subsequent procedures is low. Aortic valve repair appears to be a good option for
selected patients, particularly young patients who wish to avoid chronic anticoag-
ulation with warfarin.
Aortic valve replacement has been the standard surgical procedurefor treatment of aortic valve regurgitation since reliable prostheticvalves became available.1,2 In most centers, aortic valve repair hasbeen reserved for patients with valve leakage due to aortic disease(dissection or dilatation) or associated ventricular septal defect.Although the early and late outcomes of valve replacement have
steadily improved, there are important limitations and complications of prosthetic
valves, especially for younger individuals. Thus, valve repair may be a useful option
for selected patients.3-6
Indeed, data from several centers indicate that survival and functional outcome
after mitral valve repair are superior to outcomes following mitral valve replace-
ment; however, overall experience with repair of aortic valve regurgitation is
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relatively small, and reported series include patients having
primary valve disease as well as aortic valve regurgitation
secondary to disease of the ascending aorta or ventricular
septal defect.4,7-9 As is true for the mitral valve, etiology of
valve regurgitation would be expected to have a strong
influence on outcome of aortic valve repair, especially on
late risk of reoperation.10-12 The aims of this study were to
assess the early and late outcomes of valve repair in patients
with aortic valve regurgitation particularly as regards inci-
dence and risk of reoperation.
Patients and Methods
Patients
From February 1986 through December 2001, 160 consecutive
patients underwent aortic valve repair procedure at the Mayo
Clinic; this cohort represents 13% of all primary operations for
severe aortic valve regurgitation during the study interval. They
were operated on by 7 staff surgeons. Our investigation specifi-
cally excluded the patients who developed aortic valve regurgita-
tion associated with acute or chronic aortic dissection or ventric-
ular septal defect; also excluded were patients with annuloaortic
ectasia who underwent aortic valve-sparing operations.
We reviewed Mayo Clinic charts and operative records to
identify the patient characteristics, etiology of valve disease, op-
erative techniques, and surgical results. Late outcomes were de-
termined from Clinic records when available or from written
correspondence with patients’ physicians and direct patient contact
with mailed questionnaire or telephone interviews when necessary.
Clinical and echocardiographic data at latest follow-up were col-
lected by contacting referring physicians. This study was approved
by the Mayo Foundation Institutional Review Board, and patients
or families gave informed consent.
Patient Demographics
Of the 160 patients, 127 (79%) were men, and ages ranged from 14
to 84 years (mean 55  17 years). Important associated cardio-
vascular problems included systemic hypertension (n  56, 35%)
and coronary artery disease (n 33, 21%), congestive heart failure
(n  27, 17%), infective endocarditis (n  12, 8%), and prior
myocardial infarction (n 9, 6%). Eight patients (5%) were found
to have systemic diseases including Takayasu’s arteritis in 3,
systemic lupus erythematosus in 2, giant cell arteritis in 1, Ka-
wasaki’s disease in 1, and juvenile rheumatoid arthritis in 1. Nine
patients (6%) had undergone cardiovascular operations prior to
aortic valve repair including repair of aortic coarctation (n  3) or
other procedures. As regards functional status preoperatively, 44
patients (28%) were in New York Heart Association (NYHA)
functional class I, 50 patients (31%) were in class II, 63 (39%)
were in class III, and 3 (2%) were in class IV.
Surgical Indications and Echocardiographic Findings
Most patients were referred for operation because of severe aortic
valve regurgitation. Other indications for operation included aortic
valve regurgitation in patients referred for repair of severe mitral
valve leakage and moderate or severe aortic valve regurgitation in
patients with severe coronary artery disease who required revas-
cularization. In the latter patients, the decision for aortic valve
repair was made intraoperatively with information from trans-
esophageal echocardiography. Transesophageal Doppler echocar-
diography was used to judge adequacy of repair intraoperatively,
and transthoracic Doppler echocardiographic studies were per-
formed routinely prior to hospital dismissal.
Operative Techniques and Classification of Main
Etiology of Aortic Valve Regurgitation
All patients underwent operations via median sternotomy with
cardiopulmonary bypass established through ascending aortic can-
nulation and single or bicaval venous cannulation with normother-
mia or mild hypothermia. Profound hypothermia was used in 4
patients who required circulatory arrest for proximal aortic arch
reconstruction. The mean aortic crossclamp and cardiopulmonary
bypass times were 46  20 and 64  33 minutes, respectively.
The patients were categorized into 4 groups according to eti-
ology of aortic valve regurgitation:
1. Annular dilation (n  63, 39%). Annular dilation without
cusp prolapse or perforation can cause central valve leakage
due to inadequate cusp apposition. Mean age of patients with
this mechanism was 64  13 years. Repair was accom-
plished by commissural plication; placement of 1 or 2
pledgetted, horizontal mattress stitches with 3-0 braided
polyester suture through the aortic wall at each commissure
so as to narrow the angle of the commissures, reduce the
circumference of the annulus, and increase the surface area
of cuspal coaptation (Figure 1, A). Care was exercised to
avoid excessive narrowing leading to functional aortic ste-
nosis. Early after repair of severe aortic valve regurgitation,
patients often had higher than normal aortic valve gradients
because of a large left ventricular stroke volume, and if there
was any question of adequacy of the aortic valve area after
plication, the orifice was calibrated with a dilator to confirm
adequate annular size.
2. Bicuspid valve (n  54, 34%). In most patients with con-
genital bicuspid aortic valve disease, regurgitation is caused
by retraction and/or prolapse of the conjoint cusp; the com-
monest anatomical finding is a conjoint cusp beneath the
right and left coronary sinuses. Mean age of this group was
41  14 years. Valves were repaired by limited triangular
resection and suture repair of the median raphe with contin-
uous 5-0 polypropylene suture. This maneuver shortens and
elevates the free edge of the cusp, permitting apposition with
the noncoronary cusp (Figure 1, B). The length of the resec-
tion from the free edge toward the annulus should be no
more than 30% to 50% of the entire length to preserve the
dimension of the cusps and to avoid suture of the thinner area
of the central cusp. In a few patients with very pliable cusps,
prolapse of the conjoint cusp can be corrected by simple
plication suture without resection. Because some degree of
annular dilation almost always accompanies regurgitation of
a bicuspid aortic valve, commissural plication was combined
with cusp repair (Figure 1, B).
3. Cusp prolapse of tricuspid aortic valve (n  34, 21%).
Regurgitation of tricuspid aortic valves may be due to pro-
lapse of 1 or more cusps, usually with elongation of the free
edge. Mean age of patients in our study with this mechanism
was 62  15 years. The most commonly used technique to
Surgery for Acquired Cardiovascular Disease Minakata et al
646 The Journal of Thoracic and Cardiovascular Surgery ● March 2004
A
CD
resuspend the cusp was cusp plication near the commissure
with 5-0 polypropylene suture as described by Trusler and
colleagues.5 Other methods of repair for isolated cusp pro-
lapse included limited triangular resection and plication of
the prolapsing cusp and resuspension of the free edge of the
cusp by weaving with 5-0 polytetrafluoroethylene suture
along the free edge and anchoring it to the commissure.
4. Cusp perforation (n  9, 6%). Cusp perforation resulting
from infective endocarditis was repaired by patch closure
utilizing autologous pericardium secured with interrupted or
continuous 6-0 polypropylene sutures (Figure 1, C); mean
age of this group was 46  17 years.
Surgical methods are summarized in Table 1. The other tech-
nique used was cusp shaving; hypertrophied or calcified nodules of
Figure 1. A, Annular dilation of aortic valve causes central regurgitation. Plication stitches are placed in the aortic
wall at each commissure. B, Bicuspid aortic valve with prolapse of the conjoint cusp. Triangular resection is made
in the midportion of the conjoint cusp and then repaired. Commissural plication stitches are also inserted. C,
Perforated cusp is repaired with patch closure using pericardium.
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Arantius may prevent complete coaptation, and this can be im-
proved by thinning the area to restore pliability of the free edge (7
patients, 4%). Concomitant procedures were performed in 98
patients (61%). The most common associated operations were
mitral valve repair (42 patients, 26%) and coronary artery bypass
grafting (29 patients, 18%). Repair of dilated ascending aorta was
performed in 27 patients (17%), including graft replacement in 19
and partial wedge resection and primary closure in 8; all patients
were found to have near normal diameter of sinotubular junction.
Statistical Analysis
Postoperative survival and freedom from reoperation were esti-
mated by the Kaplan-Meier method. Overall survival was com-
pared with the expected survival of persons of the same age and
sex, as derived from vital statistics for the west north central region
of the United States. The statistical significance of observed versus
expected survival was assessed with a 1-sample log-rank test. The
associations of potential risk factors to survival and reoperation
were assessed with log-rank tests and the Cox proportional hazards
model. Data are expressed as mean  standard deviation. Early
operative mortality was defined as death occurring within 30 days
of operation or at any time during the index hospitalization.
Results
Early Results
There was 1 early death (0.6%); this occurred in an 80-year-
old man who underwent aortic valve repair combined with
mitral valve repair, coronary artery bypass grafting, and
extended left ventricular septal myectomy. The patient was
separated from cardiopulmonary bypass with minimum ino-
tropic support; however, he subsequently developed left
ventricular free wall rupture requiring multiple attempts to
repair and died in the intensive care unit due to cardiac
failure on the fifth postoperative day.
Two patients had reoperation for aortic valve re-repair
during initial hospitalization. In each patient, routine pre-
dismissal transthoracic echocardiography identified signifi-
cant new aortic valve regurgitation compared with that
present intraoperatively at the conclusion of repair. Both
patients had bicuspid aortic valves and were found to have
dehiscence at the plication sutures on the conjoint cusp.
Re-repair by resuturing the cusp was successful with satis-
factory late results.
Other nonfatal complications included exploration for
bleeding in 3 patients (1.9%), neurological event in 3 (1.9%)
and respiratory failure in 3 (1.9%).
Preoperative and postoperative echocardiographic eval-
uations of the aortic valve are summarized in Table 2.
Notice that in 11 patients, significant aortic valve regurgi-
tation was missed by the prebypass echocardiographic
study.
Late Results
Clinical follow-up was obtained in 152 of 159 hospital
survivors (96%), and the mean follow-up period was 4.2 
2.6 years (maximum follow-up 14 years). There were 16
late deaths, and half were known to be due to cardiovascular
causes including myocardial infarction in 3, aneurysm rup-
ture in 2, and stroke in 1. Importantly, there was only 1 late
death due to congestive heart failure and 1 sudden death.
There were 4 other noncardiovascular deaths and 4 un-
known deaths. Overall survival estimates at 3, 5, and 7 years
were 96%, 92%, and 89%, respectively, and as seen in
Figure 2, survival of study patients was similar to that of an
age- and sex-matched population. Estimates of freedom
from known cardiac-related death (myocardial infarction,
congestive heart failure, stroke, sudden death) at 3, 5, and 7
years were 97%, 96%, and 96%, respectively.
On univariate analysis, preoperative variables associated
with late death were coronary artery disease (P  .005) and
older age (P  .002). A multivariate analysis was not done
because of the small number of late events.
Figure 2. Probability of patient survival (overall death and car-
diac death) and expected survival of the general population of the
same age and sex (P  .78).
TABLE 1. Operative methods of aortic valve repair and
concomitant procedures (n  160)
Operative techniques
Commissural plication 154 (96%)
Partial cusp resection with plication 47 (29%)
Resuspension or cusp shortening 44 (28%)
Closure of cusp perforation 10 (6%)
Cusp shaving 7 (4%)
Concomitant procedures 98 (61%)
MV repair 42 (26%)
CABG 29 (18%)
Repair of ascending aorta 27 (17%)
Septal myectomy 9 (6%)
TV repair 5 (3%)
MVR 5 (3%)
Closure of ASD/PFO 5 (3%)
Maze procedure 4 (3%)
Membranectomy of SAS 3 (2%)
Tumor resection 2 (1%)
Left ventricular aneurysmectomy 1 (1%)
ASD, Atrial septal defect; CABG, coronary artery bypass grafting; MV,
mitral valve; MVR, mitral valve replacement; PFO, patent foramen ovale;
SAS, subaortic stenosis; TV, tricuspid valve.
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Late Reoperation and Other Valve-Related
Complications
Seventeen patients required late cardiovascular operations,
and 16 of these had aortic valve replacement (Table 3); 1
patient had thoracoabdominal aortic aneurysm repair. Mean
interval between initial operation and late aortic valve re-
operation was 2.8  2.5 years. Among patients having late
aortic valve reoperation, the etiologies of aortic valve re-
gurgitation at the initial operation were bicuspid valve in 6
patients, annular dilation in 5 patients, and cusp prolapse of
tricuspid valve in 5 patients. No patients having repair of
cusp perforation required late reoperation.
The primary indications for late reoperation were severe
aortic valve regurgitation in 13 patients, severe mitral valve
regurgitation in 1, aortic valve stenosis in 1, and ascending
aortic aneurysm in 1. Thus, late failure of the original aortic
valve repair was the primary indication for reoperation in 14
of 16 patients. Of note, there were no early deaths related to
reoperation. Cumulative risks of aortic valve reoperation at
3, 5, and 7 years were 9%, 11%, and 15%, respectively
(Figure 3). Risk of aortic valve reoperation due to severe
aortic valve regurgitation at 5 years was 10%, and for
patients who had aortic valve repair without mitral valve
procedure, risk of reoperation at 5 years was 6%.
Occurrence of late reoperation was also stratified accord-
ing to the main etiology of aortic valve regurgitation at
initial repair (Figure 4). Because the numbers of patients in
each group were relatively small, there were no significant
differences in rates of reoperation. However, the highest
rate of reoperation was seen in patients who had repair of
tricuspid aortic valves with cusp prolapse, and, again, there
were no reoperations in patients who had repair of cusp
perforations.
The late occurrences of other complications generally
considered to be valve-related were low. During follow-up,
6 patients developed gastrointestinal bleeding, 5 had stroke
or transient ischemic events, and 1 patient had intracranial
bleeding. No infective endocarditis was noted. Estimates of
freedom from stroke, bleeding, and endocarditis at 5 years
were 98%, 94%, and 100%, respectively. The linearized rate
of these complications (combined) was 1.0% per patient-
year.
Among the 143 late survivors, 27 patients (19%) were
receiving warfarin for various reasons, including thrombo-
embolism prophylaxis for a mechanical prosthesis (aortic or
mitral position, n  14), chronic atrial fibrillation (n  6),
history of deep venous thrombosis (n  3), and history of
stroke (n  2). The indication for anticoagulation was
unknown in 2 patients. Of the 130 patients who at most
recent follow-up were alive with their original aortic valve
repair, only 11 (8.5%) were on warfarin.
Follow-up Doppler echocardiographic data were ob-
tained from 104 of 130 survivors (free from death and aortic
valve reoperation). The mean interval between the date of
operation and the date of most recent transthoracic echocar-
diogram was 2.8 years. Degrees of aortic valve regurgitation
were severe in 2, moderately severe in 3, moderate in 26,
trivial to mild in 62, and none in 11. There were no patients
with hemodynamically important aortic stenosis (Table 2).
At last contact, 107 patients (75%) were in NYHA class
I, 30 (21%) were in class II, and 5 (3%) were in class III.
Discussion
Management of patients with valvular regurgitation has
changed markedly over the last 2 decades. This is particu-
larly true for mitral valve regurgitation, due to several
factors including the accuracy of echocardiography in de-
fining the severity and mechanism of valve leakage, a better
understanding of the natural history of mitral valve disease,
and the refinements and predictability of repair of degener-
ative mitral valve disease. Less progress has been made in
management of patients with chronic aortic valve regurgi-
tation, but recent studies do suggest that the traditional
TABLE 2. Echocardiographic assessment of aortic valve before and after repair
AR grade AS grade
0, n (%) 1, n (%) 2, n (%) 3, n (%) 4, n (%) 0, n (%) 1, n (%) 2, n (%) 3 or 4, n (%)
Pre-CPB* 1 (1) 10 (6) 49 (31) 40 (25) 51 (32)
Post-CPB† 40 (26) 106 (70) 6 (4) 0 (0) 0 (0)
At dismissal‡ 23 (15) 120 (77) 13 (8) 0 (0) 0 (0) 94 (65) 43 (31) 6 (4) 0 (0)
Follow-up§ 11 (11) 62 (60) 26 (25) 3 (3) 2 (2) 57 (60) 29 (31) 9 (10) 0 (0)
AR, Aortic regurgitation; AS, aortic stenosis; CPB, cardiopulmonary bypass; grade 0, none; grade 1, trivial or mild; grade 2, moderate; grade 3, moderately
severe; grade 4, severe.
*Pre-CPB data were obtained from intraoperative transesophageal echocardiography before cardiopulmonary bypass, available in 151 patients of 160.
†Post-CPB data were obtained from intraoperative transesophageal echocardiography after cardiopulmonary bypass, available in 152 patients of 160.
‡At dismissal, data were obtained from transthoracic echocardiography at the time of hospital dismissal, available in 156 patients for aortic regurgitation
and 143 patients for aortic stenosis.
§Follow-up data were obtained from transthoracic echocardiography of the patients who were free from late death and late aortic valve reoperation,
available in 104 patients for aortic regurgitation and 95 patients for aortic stenosis.
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conservative strategy of deferring valve replacement until
there is clear-cut evidence of ventricular dysfunction, pro-
gressive left ventricular enlargement, or symptoms may
result in excess mortality.13 Indeed, earlier intervention for
aortic valve repair or replacement may prove to be the best
strategy for patients who have well-documented severe aor-
tic valve regurgitation.
In contrast to the situation with degenerative mitral valve
disease, where repair is the rule rather than the exception,
operation for chronic aortic valve regurgitation usually
leads to prosthetic replacement, and concerns of clinicians
regarding late complications of prostheses only reinforces a
conservative clinical approach to patients.
Most previous reports of aortic valve repair have in-
cluded patients with acute and chronic aortic dissection,14
annuloaortic ectasia,15,16 or congenital heart problems,5,7
and the role of repair for primary aortic valve disease is not
well defined. The present study provides information on the
safety and durability of aortic valve repair in such patients.
Although patients in this series were highly selected, the
very low operative mortality compares very favorably with
contemporary reports on risk of aortic valve replacement
with biological and mechanical heart valves.1,2,17-20 Surely,
there is no suggestion that early mortality is increased with
valve repair. Our study population did not include those
patients in whom an initial attempt at valve repair was
TABLE 3. Summary of late aortic valve reoperations
Patient
Age
(y)
Interval
(mo) Etiology Concomitant procedure
Post-repair
AR (TEE) Dis-TTE AR Primary indication Redo procedure
1 68 31 Dilation 1 1 Severe AR AVR
2 75 12 Dilation Asc.Ao Rep/CABG 1 1 Severe AR AVR/CABG
3 34 51 Bicuspid 1 1 Asc.Ao Aneurysm CG
4 59 131 Dilation CABG N/A 1 Severe AR CG/CABG
5 55 23 Prolapse MV repair 2 1 Severe AR AVR/MVR
6 65 11 Prolapse MV repair 1 1 Severe AR AVR with RE
7 21 25 Bicuspid 1 1 Severe AR AVR
8 62 68 Bicuspid MV repair/maze 1 1 (AS1) Severe MR AVR/MVR
9 74 36 Prolapse MV repair 1 1 Severe AR AVR/MVR/CABG
10 53 32 Dilation MV repair 1 1 Severe AR AVR/MVR
11 21 9 Bicuspid 1 1 Severe AR AVR
12 52 13 Bicuspid 0 2 Severe AR AVR
13 73 43 Dilation MV repair 1 1 Severe AR AVR/MVR/CABG
14 57 35 Prolapse 1 2 Severe AR AVR
15 20 16 Bicuspid 1 2 Severe AR AVR
16 22 12 Prolapse MV repair 0 1 (AS2) Severe AS AVR with RE/MVR
Mean 51 34
AR, Aortic regurgitation; AS, aortic stenosis; Asc.Ao, ascending aorta; Asc.Ao Rep, ascending aortic replacement; AVR, aortic valve replacement; CABG,
coronary artery bypass grafting; CG, composite graft aortic root replacement; MS, mitral stenosis; MR, mitral regurgitation; MV, mitral valve; MVR, mitral
valve replacement; RE, aortic root enlargement; grade 0, none; grade 1, trivial or mild; grade 2, moderate; grade 3, moderately severe; grade 4, severe; Age,
age at initial operation; Interval, interval between initial and redo operation; Etiology, main etiology of aortic regurgitation at initial operation; TEE,
transesophageal echocardiography; Dis-TTE, transthoracic echocardiography at the hospital dismissal.
Figure 3. Cumulative risk of aortic valve reoperation.
Figure 4. Cumulative risk of reoperation stratified according to
the main etiology.
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unsuccessful and immediate conversion to prosthetic valve
replacement was undertaken. There were few such patients
during the study interval, and there were no operative deaths
related to an initial attempt at aortic valve repair.
The late results of aortic valve repair that have been
presented should be interpreted in the context of expected
results from prosthetic valve replacement. Certainly, re-
placement with a mechanical or a biological prosthesis
would be expected to have a lower rate of reoperation
during the first 5 to 7 years postoperatively, but this dura-
bility comes at the expense of valve-related complications,
which, for mechanical valves, occur at a rate of approxi-
mately 5% per patient-year.21 In this series, the linearized
rate of thromboembolism, anticoagulant-related bleeding,
and infective endocarditis combined was 1.0% per patient-
year.
Thromboembolism and anticoagulant-related bleeding
after aortic valve replacement are lower with biological
valves than with mechanical valves, but structural valve
deterioration is predictable with heterografts, and rates of
valve failure at 10 years postoperatively are 13% to 30% for
patients in their fifth decade of life and 18% to 25% for
patients in their sixth decade.22-24 Although our follow-up is
not sufficiently long to allow formal comparison, durability
of valve repair appears similar to that of porcine hetero-
grafts in younger patients and offers some hope of function
beyond 15 years. In the present series, the mean age of the
patients was 55 years with a freedom from reoperation of
85% at 7 years; additional observation will be necessary for
secure conclusions regarding durability in comparison to
heterograft prostheses.
Also, it should be recognized that these results represent
the learning curve for this procedure, and experience in
selection of patients and operative methods might be ex-
pected to improve subsequent results. For example, early
failure resulting from suture dehiscence at the repair site of
the bicuspid valve has not occurred since 1997, and late
breakdown at the repair site was the cause of recurrent valve
leakage in only 1 of the 14 patients who had late aortic valve
replacement for aortic valve regurgitation.
The important influence of the learning curve on late
outcome is illustrated in Figure 5, which shows the cumu-
lative risk of reoperation after mitral valve repair at our
institution during 2 decades. Rates of late reoperation have
been reduced by half in the latter portion of this experience.
Indeed, the risk of late reoperation after aortic valve repair
is very similar to the risk of late reoperation following
mitral valve repair involving the anterior leaflet in the
1980s.25
Congenital bicuspid aortic valves are present in approx-
imately 2% of the general population,26,27 and up to 63% of
people with a bicuspid aortic valve will have no significant
valve dysfunction with normal life expectancy.28 Valvular
regurgitation is a frequent presentation of bicuspid aortic
valve disease in young patients.26,27 These younger patients
might be the best candidates for valve repair. Cosgrove and
colleagues4,10,11 have reported good late durability of repair
of bicuspid valves with freedom from reoperation estimates
at 5 and 7 years of 87% and 84%, respectively, very similar
to those in the present study (91% at 5 years).
In conclusion, aortic valve repair in patients with aortic
valve regurgitation can be performed with very low mortal-
ity and morbidity. Intermediate-term follow-up suggests
that valve-related complications are very low and risk of
reoperation is acceptable, particularly when compared with
the anticipated risk of structural valve deterioration of het-
erograft valves in young patients.
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Figure 5. Cumulative risk of reoperation following mitral valve repair and aortic valve repair. AL, Anterior leaflet;
MV, mitral valve; PL, posterior leaflet.
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Discussion
Dr Lawrence H. Cohn (Boston, Mass). This is a very interesting
article, very well presented by Dr Minakata, who is a member of
one of the premier valve surgery groups in the United States, if not
the world, the Mayo Clinic. They took a look at 15 years of data
and accumulated 160 patients; that is about 10 to 12 patients per
year. My first question to you is this. Is this rate of repair increas-
ing, decreasing, or staying the same, and what might be the
denominator per year, approximately, that this fraction represents?
Dr Minakata. During the same time range, approximately
4000 patients underwent first-time aortic valve replacement due to
aortic valve disease. Of those, 1250 patients underwent aortic
valve replacement due to severe aortic valve regurgitation. The
repair rate is increasing for probably the last 5 years.
Dr Cohn. At the Brigham last year we probably did something
in the range of 5 to 8 such operations, and I certainly agree that in
any noncalcified valve in any form, whether it be bicuspid or
tricuspid, aortic valve repair should certainly be considered, but
what is not clear to me and maybe to you is your degree of comfort
with calcification of the valve. In other words, were any of these
valves partially calcified, moderately calcified? What is your com-
fort level with repairing a valve that is moderately calcified?
Dr Minakata. If there is any significant aortic stenosis, we
prefer not doing repair of the aortic valve. In terms of the degree
of calcification of the valve, if we resect the calcified portion of the
conjoining cusp and still have enough tissue to sew and plicate, I
think we can still try the repair.
Dr Cohn. Another question is, how do you test for competence
of your repair prior to closing the aorta?
Dr Minakata. Literally, there is no way to evaluate the repair
appropriately before closing the aortic wall.
Dr Cohn. No way to do that? Would Dr Schaff like to com-
ment on that maybe?
Dr Hartzell V. Schaff. Evaluation of the repair is more diffi-
cult with the aortic valve than with mitral valve repair because the
aortic root is relaxed and it is not possible to inspect the valve
under physiologic pressure. After repair of a bicuspid valve, you
can displace the 2 commissures and check for good central appo-
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sition of the cusps, but often you have to wait until the aorta is
closed to assess valve competence.
Dr Cohn. My final question is, do your good results suggest to
your team that in patients in whom you are doing mitral valve
repair that oftentimes have moderate aortic regurgitation, should
you be more, shall we say, “aggressive,” in repairing those aortic
valves along with the mitral valves?
Dr Minakata. For the last question, interestingly, if we exclude
the patients who had both mitral and aortic valve repair, the risk of
reoperation at 5 years would be about 6% versus 11% in entire
series of our paper. If patients have both diseases, mitral and aortic
valve regurgitation, they might not be good candidates for this
repair.
Dr. Robert A. Dion (Leiden, The Netherlands). I congratulate
you for this magnificent paper, and I would like to ask you which
technique you would prefer in the presence of a prolapse of 1 of
the cusps of a tricuspid aortic valve. We favor the reinforcing of
the free edge with a continuous suture of 7-0 polytetrafluoroeth-
ylene (Gore-Tex; W. L. Gore & Associates, Inc, Flagstaff, Ariz)
above the triangular resection. What would you recommend for the
monocusp failure?
Dr Minakata. There were only a couple of patients who had a
triangular resection in the tricuspid aortic valve patients. We
usually plicate using the commissural plication under each com-
missure of the prolapsing cusp so that we could decrease the length
of the free edge and increase the coaptation area, and oftentimes
we also do what we call a “Trusler stitch” to shorten the cusp.
Those are the main techniques we usually use.
Dr Schaff. Let me add to that, Dr Dion. We have used primar-
ily 3 methods: 1 would be a Trusler stitch to shorten the free edge
of the cusp near the commissures; another would be a very limited
triangular resection; and the third maneuver would be to support or
resuspend the free edge of the cusp, as you describe, with a suture
passed from outside the aorta inward and then along the free edge;
we usually use 5-0 polytetrafluoroethylene for cusp resuspension.
Dr Christophe Acar (Paris, France). Congratulations, Dr
Minakata. I wish to ask you a question concerning the identifica-
tion of the mechanics of aortic regurgitation. In your article you
mentioned that you had 40% of patients with annulus dilatation.
We find it very difficult to identify, especially on the aortic valve.
So could you tell us, how do you know that the mechanics of aortic
regurgitation were precisely annulus dilatation rather than cusp
retraction or rather than dilatation of the sinotubular junction, and
did you evaluate this using transesophageal echocardiography or
any other method?
Dr Minakata. Essentially we excluded the patients who had
dilatation of the sinotubular junction or annuloaortic ectasia from
this series. With patients who had tricuspid valve and annular
dilation, usually we felt that the main reason for regurgitation was
spreading out the cusps toward the outside of the annulus. This is
what we usually see in the elderly patients. The regurgitation was
almost always central and due to essentially dilatation of the
annulus.
Dr Schaff. I might add that, as Dr Minakata mentioned, this
series does not include patients with dilatation of the sinotubular
junction. Those are easily repaired by inserting a tube graft or
narrowing that segment of the aorta. For patients with tricuspid
valves and annular dilatation, we don’t have specific formulas to
determine the extent to which the annulus can be reduced. In
practice one often has to place those plication sutures and see if
you then have good central apposition of the three cusps. We don’t
use any formulas or specific guidelines of measurement.
Dr A. Sampath Kumar (New Delhi, India). Were there any
cases in which the aortic repair failed on the table and how did you
detect and treat this?
Dr Minakata. We encountered 2 early re-repairs. Both patients
had bicuspid valves that were found to have dehiscence in the
plication sutures on the conjoining cusps. We always try to make
a smaller resection in the conjoining cusps with probably 30% of
length of the height of the cusp so that we could avoid the tension
of the suture lines. And we also had 2 patients who had to go back
on cardiopulmonary bypass to have a better repair after initial
repair, but all patients had satisfactory results of the additional
repair or re-repair of the aortic valve.
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